Description Include: 11 videos 13 pdfs, size: 5.51 GB Target Audience: Hematology, Internal Medicine, Oncology, Pain Management, Radiation Oncology, Surgery Physician Sample video: contact me for sample video Information: Date & Location Friday, November 12, 2021, 2:00 PM – Saturday, November 13, 2021, 4:30 PM PST, Sofitel Los Angeles at Beverly Hills, 8555 Beverly Boulevard, Los Angeles, CA Target Audience Specialties – Hematology, Internal Medicine, Oncology, Pain Management, Radiation Oncology, Surgery Overview This important educational activity will provide guidance to front-line and oncology clinicians, nurses, physicians, pharmacists, nurse practitioners, physician assistants and pharmacists, with the most current information available about new agents in oncology and translating of the latest research to their patients. The conference will cover drug and treatment updates with a focus on myeloma, gynecological malignancies, hematologic malignancies, sarcoma, bladder cancer and GI malignancies. The conference features a comprehensive review of new drugs approved along with their mechanism of action, next generation CAR cell therapies and a keynote lecture outlining advances in immunotherapy. Next generation studies will also be addressed, and the conference will offer participants a session designed to provide insight into the latest advances in lung cancer treatment, including integration of new molecularly-targeted therapies and immunotherapy. Objectives Evaluate new, emerging and novel therapeutic agents, advances in care, and clinical trials data and apply relevant findings into the management of cancer patients Develop personalized treatment plans for patients based upon an evaluation of efficacy and safety of current and newly approved agents and therapeutic options Integrate appropriate strategies into clinical practice to optimize the management of patients with gynecologic malignancies to improve patient outcomes Utilize AJCC or other appropriate staging in clinical practice, including appropriate prognostic indicators and evidence-based national guidelines for treatment planning Anticipate the needs and issues of cancer survivors and develop an individualized wellness plan in partnership with cancer survivors, their families and the healthcare team   Topics: CME_Oncology_Brochure_singlepages_2021(Final).pdf Deintensification strategies for the treatment of HPV-positive Head and Neck cancer- is less more.mp4 Expert opinion for new therapeutic approaches in Her-2-positive breast cancer.mp4 Expert opinion for new therapeutic approaches in Her-2-positive breast cancer.pdf Expert opinion for new therapeutic approaches in HR breast cancer.mp4 Expert opinion for new therapeutic approaches in HR breast cancer.pdf Expert updates for treatment of gynecological malignancies.mp4 Expert updates for treatment of gynecological malignancies.pdf Immunotherapy for cancer treatment- what is new and what’s coming..mp4 Immunotherapy for cancer treatment- what is new and what’s coming..pdf Integrating precision medicine in RCC treatment. Are we there yet.mp4 Integrating precision medicine in RCC treatment. Are we there yet.pdf KEYNOTE PRESENTATION- Advances in Cellular Therapy.pdf Lung cancer treatment as paradigm for precision medicine.pdf New drugs approved in 2021 and their mechanism of action.mp4 New drugs approved in 2021 and their mechanism of action.pdf Pancreatic cancer treatment in 2021 and beyond.mp4 Precision genomics and immunotherapy- N-of-one personalized therapy.mp4 Precision genomics and immunotherapy- N-of-one personalized therapy.pdf Recent advances in bladder cancer treatment.pdf Therapeutic Implications of Germline Testing in Patients with Advanced Cancers.mp4 Therapeutic Implications of Germline Testing in Patients with Advanced Cancers.pdf Updates on new therapeutics for hematologic malignancies.mp4 Updates on new therapeutics for hematologic malignancies.pdf